| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.005 |